-
Hispanic subgroups, acculturation, and substance abuse treatment outcomes.
Chartier KG, Carmody T, Akhtar M, Stebbins MB, Walters ST, Warden D. Hispanic subgroups, acculturation, and substance abuse treatment outcomes. Journal of Substance Abuse Treatment 2015;59:74-82.
-
Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data.
Wu L, Ghitza UE, Batch BC, Pencina MJ, Rojas LF, Goldstein BA, Schibler T, Dunham AA, Rusincovitch S, Brady KT. Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data. Drug and Alcohol Dependence 2015;156:162-169.
-
Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders.
Killeen T, Brewerton TD, Campbell ANC, Cohen LR, Hien DA. Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders. American Journal of Drug and Alcohol Abuse 2015;41(6):547-52.
-
An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorder.
Mamey MR, Barbosa-Leiker C, McPherson S, Burns GL, Parks C, Roll JM. An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorder. Experimental and Clinical Psychology 2015;23(6):422-427.
-
Technology transfer for the implementation of a Clinical Trials Network on drug abuse and mental health treatment in Mexico.
Horigian VE, Marín-Navarrete R, Verdeja RE, Alonso E, Perez MA, Fernández-Mondragón J, Berlanga C, Medina-Mora ME, Szapocznik J. Technology transfer for the implementation of a Clinical Trials Network on drug abuse and mental health treatment in Mexico. Revista Panamericana de Salud Pública (Pan American Journal on Public Health) 2015;38(3):233-242
-
Anxiety and depressed mood decline following smoking abstinence in adult smokers with attention deficit hyperactivity disorder.
Covey LS, Hu M, Winhusen TJ, Lima J, Berlin I, Nunes EV. Anxiety and depressed mood decline following smoking abstinence in adult smokers with attention deficit hyperactivity disorder. Journal of Substance Abuse Treatment 2015;59:104-108.
-
Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories.
Jacobs P, Ang A, Hillhouse MP, Saxon AJ, Nielsen S, Mai BE, Mooney LJ, Potter JS, Blaine JD. Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories. American Journal on Addictions 2015;24:667-675.
-
The presence or absence of QTc prolongation in buprenorphine-naloxone among youth with opioid dependence.
Poole SA, Pecoraro A, Subramaniam GA, Woody GE, Vetter VE. The presence or absence of QTc prolongation in buprenorphine-naloxone among youth with opioid dependence. Journal of Addiction Medicine 2016;10(1):26-33.
-
Using e-technologies in clinical trials.
Rosa CL, Campbell ANC, Miele GM, Brunner M, Winstanley EL. Using e-technologies in clinical trials. Contemporary Clinical Trials 2015;45(Part A):41-54.
-
Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems.
Sanchez K, Walker NR, Campbell ANC, Greer TL, Hu M, Grannemann BD, Nunes EV, Trivedi MH. Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems. Substance Abuse 2015;36(3):297-303